News Image
CNBCTV18

Q2 Results Highlights: Max Healthcare profit up 74%, Narayana Hrudayala profit up 30%

Published on 14/11/2025 09:18 PM

We will now wrap up the blog. Good night, folks!

Max Healthcare Q2 Results

Narayana Hrudayala Q2 Results

Net profit (RD)83% at ₹78.06 crore vs ₹457.03 crore (YoY)

Revenue (RD)25.6% at ₹1,851 crore vs ₹2,489 crore (YoY)

EBITDA (RD)35.4% at ₹585 crore vs ₹905 crore (YoY)

Margin at 31.6% vs 36.3%

Net profit at ₹888 crore vs ₹255 crore (YoY)

Revenue (GU)30.8% at ₹1,810 crore vs ₹1,383 crore (YoY)

EBITDA (RD) 12.7% at ₹364 crore vs ₹416 crore (YoY)

Margin at 20.1% vs 30.1% (YoY)

Oil India Q2 Results

Glenmark Pharma Q2 Results

Exide Industries Q2 Results

Net Profit At ₹221 Cr Vs CNBC-TV18 Poll Of ₹319 Cr

Revenue At ₹4,178 Cr Vs CNBC-TV18 Poll Of ₹4,459 Cr

EBITDA At ₹394.5 Cr Vs CNBC-TV18 Poll Of ₹533 Cr

Margin At 9.4% Vs CNBC-TV18 Poll Of 12%

Inox Wind Q2 Results

Utkarsh SFB Q2 Results

Sun TV Q2 Results

Godawari Power & Ispat Q2 Results

VIP Industries Q2 Results

Siemens Q4SY25 Results

RCF Q2 Results

On a standalone basis, the entity reported an adjusted loss of ₹237 crore compared to a profit of ₹15 crore last year. Revenue for the same quarter increased by 6% to ₹12,751 crore from ₹12,023 crore last year.

Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) more than halved to ₹303 from ₹717 crore, while EBITDA margin narrowed to 2.4% from 6% last year.

For Jaguar Land Rover, the loss before tax and exceptional items during the quarter stood at £485 million. Revenue also declined 24.3% from the same quarter last year to £24.9 billion. EBITDA margin stood at a negative 1.6%, while EBIT margin stood at a negative 8.6%, down 1,370 basis points from last year.

– Investment Spend Is Expected To Remain At £18 Bn Over five years From FY24

– FY26 Guidance Has Been Revised, EBIT Margin Cut To 0-2% From 5-7%

– Free Cash Outflow Revised To £2.2-2.5 Bn From Close To Zero

– Revenue from operations down 13.5% from last year to ₹72,449 crore from ₹83,656 crore

– EBITDA loss of ₹1,404 crore from profit of ₹9,914 crore last year

– Exceptional gain of ₹2,608 crore

– Stock ended 1.7% lower ahead of the earnings announcement at ₹391.2

Shares of IPCA Labs have surged as much as 12% today after some positive comments from the management in its earnings call.

The management highlighted that the consolidated EBITDA margin is likely to be 1% better from the current guidance of 20% for the full year.

The management also expects business growth of almost around 8% to 9% for the generics formulations business.

– Net profit up 17.3% from last year to ₹115.4 crore from ₹98.4 crore last year

– Revenue up 10% from last year to ₹1,511 crore from ₹1,370 crore

– EBITDA up 13.3% from last year to ₹223 crore from ₹196.5 crore

– EBITDA margin at 15% from 14.3% last year

– Stock surges to the day’s high, now up 4.1% at ₹208.48

During the quarter, there was a one-time JV loss of ₹26 crore, compared to a one-time gain of ₹23 crore.

Adjusted for that, the profit would have been higher from last year.

– Net profit down 16.2% from last year to ₹83.5 crore from ₹99.6 crore

– Revenue up 34% to ₹921.3 crore from ₹689 crore

– EBITDA nearly doubles from last year to ₹120 crore, up 89% from ₹62.2 crore

– EBITDA margin expands by 400 basis points to 13% from 9% last year

– Stock surges to the day’s high, up 3% to ₹196

– Net profit up to ₹20 crore from ₹2.5 crore last year

– Revenue up 4.4% from last year to ₹345 crore from ₹330.4 crore

– EBITDA up 46% from last year to ₹49 crore

– EBITDA margin expands to 14.2% from 10.2% last year

– Stock jumps 5.3% after the results announcement at ₹208.2

– Net profit down 16.4% from last year to ₹107 from ₹128 crore

– Revenue down 5% from last year to ₹404.5 crore from ₹424 crore

– EBITDA down 20% to ₹16.3 crore from ₹20.3 crore

– EBITDA margin at 4% from 4.8% last year

– Shares fall to the lows of the day, down 3% at ₹4,388.7

– Stock is down 22% so far in 2025

– Net profit up 10% from last year to ₹27.5 crore from ₹25 crore last year

– Revenue up 18% to ₹492 crore from ₹416 crore last year

– EBITDA up 13% from last year to ₹73 crore from ₹64.5 crore

– EBITDA margin at 14.8% from 15.5% last year

– Stock recovers from the lows of the day, now up 2% at ₹137.6

– Net profit up 4.6% from last year to ₹52 crore from ₹50 crore

– Revenue up 5.6% from last year to ₹1,782 crore from ₹1,688 crore

– EBITDA up 10.4% year-on-year to ₹234 crore from ₹212 crore

– EBITDA margin at 13% from 12.5% last year

– Stock jumps 4.5% after the earnings announcement to the day’s high of ₹3,855.7

– Net profit at ₹466 crore from ₹128 crore last year

– Profit aided by one-time gain of ₹474 crore

– Excluding one-time gain, net loss of ₹8 crore this quarter

– Revenue down 11% from last year to ₹527.6 crore

– EBITDA margin down to 13.2% from 24% last year

– Stock down 4.5% after the earnings announcement at ₹562.4

– Net profit down 23.5% to ₹518 crore from ₹673 crore last year

– Revenue flat, down 0.6% to ₹1,363 crore from ₹1,371 crore last year

– EBITDA down 28% from last year to ₹579 crore from ₹804 crore

– EBITDA margin at 42.5% from 58.6% last year

– Stock falls to the day’s low, down 1.6% at ₹812.8NewsLive TVMarketPopular CategoriesCalculatorsTrending NowLet's Connect with CNBCTV 18Network 18 Group :©TV18 Broadcast Limited. All rights reserved.